Evaro Raises $25M Series A

Evaro, a UK-based NHS-licensed digital healthcare platform, has raised a $25 million Series A funding round to scale its clinical care services and expand strategic business partnerships. The company currently serves 2 million patients and aims to reach 10 million users within three years.

Investors

The round was led by AlbionVC. Additional participants include Cornerstone VC, Simplyhealth Ventures, Exceptional Ventures, and BBI.

Evaro Use of Funds

The company intends to use the capital to accelerate its healthcare-as-a-service model across three key segments: consumer brands looking for new revenue streams, healthcare organizations aiming to expand digital capacity, and employers seeking to offer health benefits to their workforces.

About Evaro

Founded in 2018 by emergency physician Dr. Thuria Wenbar and pharmacist researcher Dr. Oskar Wenbar, Evaro provides regulated, technology-enabled healthcare infrastructure that allows consumer brands, healthcare organisations, and employers to integrate clinical consultations, remote diagnostics, prescription services, medication dispensing, and aftercare into their existing platforms.

Funding Details

Company Website: https://evaro.com

Company: Evaro
Raised: $25M
Round: Series A
Funding Date: January 2026
Lead Investor: AlbionVC
Additional Investors: Cornerstone VC, Simplyhealth Ventures, Exceptional Ventures, BBI
Software Category: HealthTech
Source: https://www.cornerstonevc.co/2026/01/27/evaro-raises-25m-series-a/